HARVARD BIOSCIENCE INC - Common Stock (HBIO)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
44,666,667
Number of holders
85
Total 13F shares, excl. options
26,562,238
Shares change
+5,971,439
Total reported value, excl. options
$82,344,380
Value change
+$19,093,143
Number of buys
61
Number of sells
17
Price
$3.10

Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2020

As of 30 Jun 2020 HARVARD BIOSCIENCE INC - Common Stock (HBIO) had 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 26,562,238 shares of stock of the company.
Largest 10 holders included BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, DALTON GREINER HARTMAN MAHER & CO, KENNEDY CAPITAL MANAGEMENT, INC., ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC..
This table shows 85 institutional shareholders of the security as of 30 Jun 2020.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.